Mayank Gandhi - 26 Sep 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Chief Business Officer
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Mayank Gandhi
Issuer symbol
EFTR on OTC
Transactions as of
26 Sep 2022
Net transactions value
$0
Form type
4
Filing time
28 Sep 2022, 16:47:51 UTC
Next filing
19 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +500,000 $0.000000 500,000 26 Sep 2022 Common Stock 500,000 $0.5650 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests 25% on September 26, 2023, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.